REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Immulab Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Direct Selling Establishments | Scientific Research and Development Services
Full name: Immulab Sp. z o.o. Profile Updated: May 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Immulab Sp. z o.o. is based in Poland. The head office is in Krakow. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was established on January 30, 2020. From the latest financial highlights, Immulab Sp. z o.o. reported a net sales revenue drop of 27.1% in 2023. During that time, Immulab Sp. z o.o.’s total assets decreased by 23.24%.

Headquarters
Ul. Jozefa Marcika 6
Krakow; Malopolskie; Postal Code: 30-443

Contact Details: Purchase the Immulab Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Immulab Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Immulab Sp. z o.o. report to view the information.
Incorporation Date:
January 30, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Immulab Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-27.1%▼
Total operating revenue
-27.1%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-23.24%▼
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
1991.83%▲
Debt to Equity Ratio
N/A
Quick Ratio
178.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo